scholarly journals The Public Health Road Map to Respond to the Growing Dementia Crisis

2020 ◽  
Vol 4 (1) ◽  
Author(s):  
Benjamin S Olivari ◽  
Molly E French ◽  
Lisa C McGuire

Abstract As the proportion of older adults in the United States is projected to increase dramatically in the coming decades, it is imperative that public health address and maintain the cognitive health of this growing population. More than 5 million Americans live with Alzheimer’s disease and related dementias (ADRD) today, and this number is projected to more than double by 2050. The public health community must be proactive in outlining the response to this growing crisis. Promoting cognitive decline risk reduction, early detection and diagnosis, and increasing the use and availability of timely data are critical components of this response. To prepare state, local, and tribal organizations, CDC and the Alzheimer’s Association have developed a series of Road Maps that chart the public health response to dementia. Since the initial Healthy Brain Initiative (HBI) Road Map release in 2007, the Road Map has undergone two new iterations, with the most recent version, The HBI’s State and Local Public Health Partnerships to Address Dementia: The 2018–2023 Road Map, released in late 2018. Over the past several years, significant advances were made in the science of risk reduction and early detection of ADRD. As a result, the public health response requires a life-course approach that focuses on reducing risk and identifying memory issues earlier to improve health outcomes. The most recent Road Map was revised to accommodate these strides in the science and to effect change at the policy, systems, and environment levels. The 2018–2023 Road Map identifies 25 actions that state and local public health agencies and their partners can implement to promote cognitive health and address cognitive impairment and the needs of caregivers. The actions are categorized into four traditional domains of public health, and the Road Map can help public health and its partners chart a course for a dementia-prepared future.

2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 720-720
Author(s):  
Heidi Holt

Abstract This presentation will demonstrate an innovative strategic planning effort, coined Action Institutes (AI’s), which are designed to promote the implementation of CDC’s “The Healthy Brain Initiative’s State and Local Public Health Partnerships to Address Dementia” and the “Road Map for Indian Country.” Both of these documents outline how the champions of public health and their partners can create a statewide effort to promote brain health, increase early diagnosis, address cognitive impairment for individuals living in the community, and help meet the needs of care partners. The purpose of these 1-2-day AI’s is to familiarize leaders with the topic, encourage their adoption into current priority setting, and guide participants in creating action plans. The CDC’s Alzheimer’s Disease and Healthy Aging Program is conducting a series of these AIs, which are made possible through partnerships with the Association of State and Territorial Health Officials and the National Indian Health Board.


2019 ◽  
Vol 3 (Supplement_1) ◽  
pp. SS365-SS365
Author(s):  
Heidi Holt ◽  
Blythe S Winchester

Abstract This landmark document, The Healthy Brain Initiative: Road Map for Indian Country, is the first-ever public health guide focused on dementia in American Indian/Alaska Native (AI/AN) communities. It is intended as a tool for leaders of the 573 federally recognized Indian tribes, as well as state-recognized tribes, to engage their communities in this important issue. Early in the development of the HBI Public Health Road Map for Dementia, CDC recognized strategies that may work for state and local public health agencies likely would need to be tailored by native communities due to culture and unique contexts. This Road Map for Indian Country (Road Map) can be used to support a dialogue within a Native community about how to promote wellness across the lifespan and best support older adults with dementia, their families, and caregivers. The panel will consist of 5 presenters and 1 discussant. Bill Benson, International Association of Indigenous Aging, will discuss the background and need for the project. Molly French, the Alzheimer’s Association, will describe the process used to create the Road Map. Heidi Holt, CDC, will describe the content and goals of the Road Map. Kelsey Donnellan, Association for State and Territorial Health Officials (ASTHO), will present key Indian Country products and Messages that accompany the Road Map. Lisa McGuire will present relevant Behavioral Risk Factor Data, including data specific to the AI/AN population. The discussant will wrap up the panel and provide unique insights as to the use and future for this important document.


2020 ◽  
Vol 4 (Supplement_1) ◽  
pp. 720-720
Author(s):  
Lisa McGuire

Abstract The Healthy Brain Initiative (HBI) seeks to advance public health awareness of and action on ADRD as a public health issue. The HBI Road Map Series, State and Local Public Health Partnerships to Address Dementia: The 2018–2023 Road Map (S&L RM) and Road Map for Indian Country (RMIC), provide the public health with concrete steps to respond to the growing burden of ADRD in communities, consistent with the aim of the Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act (P.L. 115-406). This series of RMs for state, local, and tribal public health provide flexible menus of actions to address cognitive health, including ADRD, and support for dementia caregivers with population-based approaches. This session will describe how the initiative evolved over the past 15 years including policy and implementation success stories.


2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Ying Zhang ◽  
Yijie Huang ◽  
Tao Ai ◽  
Jun Luo ◽  
Hanmin Liu

Abstract Background Following the outbreak of the COVID-19 pandemic, a change in the incidence and transmission of respiratory pathogens was observed. Here, we retrospectively analyzed the impact of COVID-19 on the epidemiologic characteristics of Mycoplasma pneumoniae infection among children in Chengdu, one of the largest cities of western China. Method M. pneumoniae infection was diagnosed in 33,345 pediatric patients with respiratory symptoms at the Chengdu Women’s & Children’s Central Hospital between January 2017 and December 2020, based on a serum antibody titer of ≥1:160 measured by the passive agglutination assay. Differences in infection rates were examined by sex, age, and temporal distribution. Results Two epidemic outbreaks occurred between October-December 2017 and April-December 2019, and two infection peaks were detected in the second and fourth quarters of 2017, 2018, and 2019. Due to the public health response to COVID-19, the number of positive M. pneumoniae cases significantly decreased in the second quarter of 2020. The number of M. pneumoniae infection among children aged 3–6 years was higher than that in other age groups. Conclusions Preschool children are more susceptible to M. pneumoniae infection and close contact appears to be the predominant factor favoring pathogen transmission. The public health response to COVID-19 can effectively control the transmission of M. pneumoniae.


2007 ◽  
Vol 13 (5) ◽  
pp. 461-464 ◽  
Author(s):  
Johannes Schnitzler ◽  
Justus Benzler ◽  
Doris Altmann ◽  
Inge Mücke ◽  
Gérard Krause

2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Kristin E. Schneider ◽  
Glenna J. Urquhart ◽  
Saba Rouhani ◽  
Ju Nyeong Park ◽  
Miles Morris ◽  
...  

Abstract Background Naloxone distribution programs have been a cornerstone of the public health response to the overdose crisis in the USA. Yet people who use opioids (PWUO) continue to face a number of barriers accessing naloxone, including not knowing where it is available. Methods We used data from 173 PWUO from Anne Arundel County, Maryland, which is located between Baltimore City and Washington, DC. We assessed the prevalence of recently (past 6 months) receiving naloxone and currently having naloxone, the type(s) of the naloxone kits received, and the perceived ease/difficultly of accessing naloxone. We also assessed participants knowledge of where naloxone was available in the community. Results One third (35.7%) of participants had recently received naloxone. Most who had received naloxone received two doses (72.1%), nasal naloxone (86.9%), and education about naloxone use (72.1%). Most currently had naloxone in their possession (either on their person or at home; 78.7%). One third (34.4%) believed naloxone was difficult to obtain in their community. Only half (56.7%) knew of multiple locations where they could get naloxone. The health department was the most commonly identified naloxone source (58.0%). Identifying multiple sources of naloxone was associated with being more likely to perceive that naloxone is easy to access. Discussion Our results suggest that additional public health efforts are needed to make PWUO aware of the range of sources of naloxone in their communities in order to ensure easy and continued naloxone access to PWUO.


Sign in / Sign up

Export Citation Format

Share Document